Category: biotech

.Versus the scenery of a Cas9 license battle that rejects to die, Editas Medicine is moneying in a portion of the licensing civil rights from

.Editas Medicines has actually signed a $238 million biobucks deal to blend Genevant Scientific research’s fat nanoparticle (LNP) tech with the genetics therapy biotech’s recently

.Though Alkeus Pharmaceuticals’ oral eye health condition possession neglected to significantly lessen geographical atrophy (GA) sore development, the biotech is citing “medically purposeful” outcomes and

.Welcome to this week’s Chutes &amp Ladders, our roundup of considerable management hirings, firings and also retirings across the business. Satisfy deliver the compliment– or

.Compass Pathways’ adventure to phase 3 experimental depression data is actually taking a lot longer than anticipated. With the trials overrunning through months, the biotech

.Tip has mentioned stage 3 data on its own near-approval ache drug candidate suzetrigine, clarifying just how the non-opioid painkiller combines along with ibuprofen as

.Mandarin insulin producer Gan &amp Lee Pharmaceuticals is actually wading into the obesity globe along with an injectable GLP-1 agonist that hammered Novo Nordisk’s Ozempic

.China-based Minghui Drug has actually linked its own thyroid eye condition treatment to a decline in eye protruding in a little phase 1b/2 professional test.The

.Cassava Sciences has accepted pay $40 thousand to fix an examination into cases it created misleading claims regarding phase 2b information on its own Alzheimer’s

.Gritstone biography has actually introduced bankers to look into “possible value-maximizing techniques” after its phase 2 colon cancer injection records disappointed the runaway results needed